Linagliptin CAS 668270-12-0 Tsarkakewa ≥99.0% (HPLC) Hoton Factory

Linagliptin CAS 668270-12-0 Tsarkakewa ≥99.0% (HPLC) Factory

Takaitaccen Bayani:

Sunan Chemical: Linagliptin

Saukewa: 668270-12

Tsafta: ≥99.0% (HPLC)

Bayyanar: Fari ko Kashe-White Crystalline Foda

Linagliptin don kula da nau'in ciwon sukari na II

API, Babban inganci, Samar da Kasuwanci

E-Mail: alvin@ruifuchem.com

Aika mana imel

Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Samar da Maƙera, Babban Tsafta, Samar da Kasuwanci
Sunan Chemical: Linagliptin
Saukewa: 668270-12

Abubuwan Sinadarai:

Sunan Sinadari	Linagliptin
Makamantu	BI-1356;8-[(3R) -3-Amino-1-piperidinyl] -7- (2-butynyl) -3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl) methyl] -1H - purine-2,6-dione
Lambar CAS	668270-12-0
Lambar CAT	RF-API105
Matsayin Hannun jari	A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta	Saukewa: C25H28N8O2
Nauyin Kwayoyin Halitta	472.54
Matsayin narkewa	197.0 zuwa 200.0 ℃
Solubility	Mai narkewa a cikin DMSO
Alamar	Ruifu Chemical

Ƙayyadaddun bayanai:

Abu	Ƙayyadaddun bayanai
Bayyanar	Fari ko Kashe-White Crystalline Foda
NMR	Daidaita Da Tsarin
Tsarkake / Hanyar Bincike	≥99.0% (HPLC)
Asara akan bushewa	≤0.50%
Ragowa akan Ignition	≤0.10%
Karfe masu nauyi	≤10ppm
Abubuwa masu alaƙa
Tsaftace Guda Daya	≤0.50%
Jimlar ƙazanta	≤1.0%
Isomer	≤0.15%
Ragowar Magani
Methanol	≤3000ppm
isopropanol	≤5000ppm
DMF	≤800ppm
Dichloromethane	≤600ppm
Matsayin Gwaji	Matsayin Kasuwanci
Amfani	API

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / Kwali Drum, ko bisa ga abokin ciniki ta bukata.

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi.

Amfani:

FAQ:

Aikace-aikace:

Linagliptin (CAS: 668270-12-0) shine mai hana DPP-4 wanda Boehringer Ingelheim ya haɓaka don maganin nau'in ciwon sukari na II.Halayen harhada magunguna guda biyu waɗanda ke keɓance linagliptin ban da sauran masu hana DPP-4 shine cewa yana da bayanin martabar pharmacokinetic mara layi kuma ba a kawar da shi da farko ta tsarin koda.Linagliptin (sau ɗaya a rana) FDA ta Amurka ta amince da ita a ranar 2 ga Mayu 2011 don maganin ciwon sukari na II.Boehringer Ingelheim da Lilly ne ke tallata shi.Linagliptin, wanda aka sayar a ƙarƙashin sunan alamar Tradjenta da sauransu.Ana amfani dashi tare da motsa jiki da abinci.